United States:
Cannabis: Investing In One Of The Fastest "Growing" Segments Of The Life Sciences Industry (Video)
16 May 2017
Duane Morris LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Duane Morris partners Seth Goldberg and David Feldman, members
of Duane Morris'
Cannabis Law Practice Group, were panelists for an ACG webinar,
"Cannabis: Investing in One of the Fastest "Growing"
Segments of the Life Sciences Industry" on May 9, 2017. You
may view the webinar below.
Disclaimer: This Alert has been
prepared and published for informational purposes only and is not
offered, nor should be construed, as legal advice. For more
information, please see the firm's
full disclaimer.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...